Literature DB >> 6227636

Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.

S Takada, Y Ueda, Y Murakawa, N Suzuki, T Sakane.   

Abstract

Normal human peripheral blood T lymphocytes activated by concanavalin A (Con A) were fractionated into OKT4+ and OKT8+ populations by complement-dependent cell lysis using OKT8 and OKT4 antibodies, respectively. By using the preferential ability of some, but not all, Con A-activated T cells to form rosettes with autologous erythrocytes, each population was further divided into autorosetting cells and nonautorosetting cells, and thus Con A-activated OKT4+ autorosetting, OKT4+ nonautorosetting, OKT8+ autorosetting, and OKT8+ nonautorosetting cells were obtained. The immune regulatory function of these populations was then investigated using a pokeweed mitogen-driven B cell plaque-forming cell system. These studies demonstrated that (a) autorosetting cells can exert potent suppressor activity regardless of their phenotypes of OKT4+ and OKT8+ antigens, and fail to help B cell differentiation; suppressor function mediated by these cells is radiosensitive; moreover, receptors for autologous erythrocytes may constitute either the interleukin 2 (IL2) receptors themselves or a component of an IL2 receptor-effector complex involved in modulating the growth signal that IL2 transmits to T cells; (b) OKT4+ nonrosetting cells serve adequately as radioresistant helper cells, but are devoid of suppressor cells; and (c) OKT8+ nonrosetting cells are found to lack either suppressor or helper activity, suggesting that they may belong to a T lymphocyte subset distinct from the subsets related to immune regulation. The results lead us, therefore, to the conclusion that there may exist functional heterogeneities among both the OKT4+ and OKT8+ populations; these heterogeneities can be dissected by virtue of the autologous erythrocyte rosette technique.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6227636      PMCID: PMC437047          DOI: 10.1172/JCI111171

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Immunoregulatory aberrations in systemic lupus erythematosus.

Authors:  A S Fauci; A D Steinberg; B F Haynes; G Whalen
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

2.  The role of mitogenic lectins in T-cell triggering.

Authors:  E L Larsson; A Coutinho
Journal:  Nature       Date:  1979-07-19       Impact factor: 49.962

3.  Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.

Authors:  A Sagawa; N I Abdou
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

4.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

5.  Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction.

Authors:  R Palacios; L Llorente; D Alarcón-Segovia; A Ruíz-Arguelles; E Díaz-Jouanen
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

Review 6.  Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings.

Authors:  E L Reinherz; S F Schlossman
Journal:  N Engl J Med       Date:  1980-08-14       Impact factor: 91.245

7.  Studies of immune functions of patients with systemic lupus erythematosus. V. T cell suppressor function and autologous mixed lymphocyte reaction during active and inactive phases of disease.

Authors:  T Sakane; A D Steinberg; I Green
Journal:  Arthritis Rheum       Date:  1980-02

8.  Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies.

Authors:  C Morimoto; E L Reinherz; T Abe; M Homma; S F Schlossman
Journal:  Clin Immunol Immunopathol       Date:  1980-08

9.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

10.  Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus.

Authors:  C Morimoto; E L Reinherz; S F Schlossman; P H Schur; J A Mills; A D Steinberg
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more
  4 in total

1.  In vitro selective effect of melphalan on human T-cell populations.

Authors:  S Ben-Efraim; L Komlos; J Notmann; J Hart; I Halbrecht
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

2.  OKT4+ and OKT8+ T lymphocytes produce soluble factors that can modulate growth and differentiation of human B cells.

Authors:  T Sakane; Y Ueda; N Suzuki; Y Niwa; T Hoshino; T Tsunematsu
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

3.  Changes in T lymphocyte subsets following injury. Assessment by flow cytometry and relationship to sepsis.

Authors:  J B O'Mahony; J J Wood; M L Rodrick; J A Mannick
Journal:  Ann Surg       Date:  1985-11       Impact factor: 12.969

4.  Implications for the role of cognate interactions in in vitro human B cell activation by Staphylococcus aureus Cowan I and pokeweed mitogen.

Authors:  N Suzuki; T Sakane; Y Ueda; Y Murakawa; T Tsunematsu
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.